The pharmaceutical giant Eli Lilly's stock has been riding the skyrocketing demand for its weight loss injection Zepbound and ...

Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by ...

Eli Lilly briefly crossed the $1 trillion market cap threshold, the first drug maker to ever reach that milestone.

Lilly becomes the first pharmaceutical company to hit that threshold, joining a select club of mostly tech companies.

Digital health company Waltz Health said on Friday it has launched a program to offer popular weight-loss drugs from Novo ...

LLY???s newest approvals and pipeline deals add fresh momentum to revenue growth as the company expands beyond its GLP-1 ...

Separately, companies, including digital health firm Waltz Health and cardiometabolic care provider 9amHealth announced ...

Eli Lilly's stock has captured attention as consensus analyst price targets have risen from $919 to $1,003 per share. This ...

Eli Lilly stock has regained all-time highs, outpacing rivals in the obesity drug market. Click here to read my latest ...

South Korea’s newest billionaire is Lee Sang-hoon, founder of ABL Bio, after it struck a $2.6 billion licensing and joint ...

Eli Lilly shares have room to keep going as GLP-1 drugs spread their reach.

Wall Street projects the global weight-loss drug market could reach $150 billion by 2030, with Lilly and Novo Nordisk ...